Tags (2) : Kite Pharma
		 
				  Gilead & Kite Pharma Unveil Breakthrough Cancer Research at ASCO & EHA 2025
 
				 Gilead & Kite Pharma Unveil Breakthrough Cancer Research at ASCO & EHA 2025
			 
		 
			 05/29/2025 | Companies
			 
			 
				 American Society of Clinical Oncology, 
				 ASCO, 
				 cancer research, 
				 cancer treatment, 
				 CAR T-cell therapy, 
				 clinical trials, 
				 collaborative research, 
				 EHA, 
				 European Hematology Association, 
				 GileadNews, 
				 hematology, 
				 innovative therapies, 
				 investigational therapy, 
				 Kite Pharma, 
				 metastatic triple-negative breast cancer, 
				 oncology, 
				 Phase 2 results, 
				 recurrent glioblastoma, 
				 refractory multiple myeloma, 
				 relapsed multiple myeloma
			 
			 
		 Most Popular Now
	 
		 Environment News
	 
		 Compliance
	 
		 Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com
	 
	 

 
			  
			  
 
 Companies
 
				 Companies